Asian Hospital and Healthcare Management

03/08/2026

Imagine reaching hundreds—even thousands—of potential customers without geographical limits.

That's exactly what Webinar Services can do.

People no longer want constant sales pitches.

They want valuable insights.
They want experts.
They want solutions.

A successful webinar helps you:

✨ Build credibility
✨ Launch products
✨ Generate quality leads
✨ Connect with your audience
✨ Grow your brand visibility

The businesses growing the fastest today aren't always spending more on advertising.

They're creating experiences that educate, inspire, and convert.

🔗 https://www.asianhhm.com/mediapacks

Is your business using webinars yet?

Tell us in the comments!

31/07/2026

A new facility marks an important milestone for CereVasc.

CereVasc has opened a new manufacturing and research facility in Wilmington, Massachusetts, as it advances development of its investigational eShunt® System.

The announcement follows two major milestones: completion of enrollment in the STRIDE pivotal trial and the close of an oversubscribed $85 million Series C financing.

The new facility features an ISO Class 7 clean room along with infrastructure for assembly, inspection, testing and manufacturing.

The eShunt System is being developed as a minimally invasive alternative to conventional shunt surgery for communicating hydrocephalus.

👉 Read the full announcement: https://www.asianhhm.com/pressreleases/cerevasc-opens-new-massachusetts-facility

31/07/2026

🩺 A significant regulatory milestone for kidney care technology.

Nipro has received FDA clearance for ELISIO HX, marking an important step forward for its haemodialysis portfolio.

The clearance underscores the continued development of medical technologies supporting dialysis and renal care.

👉 Read the full story: https://www.asianhhm.com/news/nipro-receives-fda-clearance-for-elisio-hx

31/07/2026

🌍 Get ready for MEDICAL FAIR ASIA 2026!

Whether you're discovering new technologies, planning meetings with exhibitors, or selecting conference sessions, the available planning resources will help you prepare for a successful visit.

📅 9–11 September 2026
📍 Marina Bay Sands, Singapore

Explore:
✅ Show Preview
✅ Exhibitor List
✅ Product Highlights
✅ Conference Programme
✅ Group Registration

👉 Start planning your visit today and maximize every opportunity at MEDICAL FAIR ASIA 2026: https://industry.asianhhm.com/clientemailblast/1785414159-Medical-Fair-Asia.html

30/07/2026

A new milestone for tricuspid valve replacement research.

VDyne has announced the first patient enrolled and treated in the TRIVITA US IDE pivotal study of its TriNova™ Transcatheter Tricuspid Valve Replacement System.

The prospective, global, multicenter randomized controlled study will evaluate the safety and effectiveness of TriNova in patients with severe or greater tricuspid regurgitation who are suitable for valve replacement.

The study will compare TriNova head-to-head with the commercially available Edwards EVOQUE™ TTVR system and is planned across the US and Europe with up to 70 participating sites.

👉 Read the full story: https://www.asianhhm.com/pressreleases/vdyne-announces-first-patient-treated-in-trivita

30/07/2026

From medical imaging to real-time surgical navigation.

Smith+Nephew has secured FDA De Novo classification for its AI-powered TESSA Spatial Surgery System.

The platform combines preoperative MRI or CT scans with cloud-based AI and accelerated computing to create patient-specific 3D anatomical models. During surgery, these models are overlaid onto live 4K arthroscopic video to support real-time navigation.

The first approved use is femoral ACL reconstruction of the knee.

👉 Explore the full story: https://www.asianhhm.com/news/smithnephew-secures-fda-de-novo-classification

29/07/2026

Real-world evidence is shaping the future of structural heart care.

Abbott has announced the launch of the TREAT TR post-market clinical study to evaluate real-world outcomes of its TriClip™ Transcatheter Edge-to-Edge Repair (TEER) System for patients with tricuspid regurgitation.

The study aims to generate additional clinical evidence from routine medical practice, supporting a deeper understanding of patient outcomes with this dedicated structural heart technology.

👉 Read More: https://www.asianhhm.com/pressreleases/abbott-initiates-clinical-study-to-show-outcomes

29/07/2026

🌟 Funding fuels the future of pediatric healthcare innovation.

Navi Medical Technologies has announced a successful A$6.8 million funding round to support the U.S. commercialization of its FDA-cleared Neonav® technology.

The investment will help expand manufacturing, grow its commercial operations, and bring advanced vascular access technology to leading children's hospitals—supporting safer care for neonatal and pediatric patients.

👉 Discover more : https://www.asianhhm.com/news/navi-medical-technologies-raises-a68-million

29/07/2026

Not all cancer cells die the same way.

While one pathway has been studied for decades, another is opening exciting new possibilities for treating resistant tumors.

💡 What makes Ferroptosis different from apoptosis—and why is everyone talking about it?

Find out the science behind this breakthrough.

👉 Read more: https://www.asianhhm.com/articles/ferroptosis-vs-apoptosis

Curious why ferroptosis vs apoptosis kill cancer cells differently? Explore the science behind two powerful cell death pathways reshaping cancer therapy.

22/07/2026

📢 The New AsianHHM Newsletter Has Arrived!

Looking for the latest trends transforming healthcare?

The July 2026 AsianHHM e-Newsletter is packed with valuable insights designed for healthcare leaders, hospital executives, clinicians, researchers, and healthcare technology professionals.

✨ Inside this edition:
✅ Trending Healthcare News
✅ Expert Articles
✅ Exclusive Interviews
✅ Research Insights
✅ HealthTech & AI Innovations
✅ Global Healthcare Events

Stay informed. Stay inspired. Stay ahead of the future of healthcare.

📖 Read now: https://industry.asianhhm.com/e-newsletters/1784709584-AHHM-July-26.html

📩 Subscribe today and receive the latest healthcare innovations directly in your inbox every month.